ArticleEuropean journal of neurology2024

Lenalidomide in the treatment of anti-myelin-associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose.

Amro M Stino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.